lignans and Squamous-Cell-Carcinoma-of-Head-and-Neck

lignans has been researched along with Squamous-Cell-Carcinoma-of-Head-and-Neck* in 3 studies

Reviews

1 review(s) available for lignans and Squamous-Cell-Carcinoma-of-Head-and-Neck

ArticleYear
Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.
    Molecules (Basel, Switzerland), 2016, Nov-24, Volume: 21, Issue:12

    Despite the development of more advanced medical therapies, cancer management remains a problem. Head and neck squamous cell carcinoma (HNSCC) is a particularly challenging malignancy and requires more effective treatment strategies and a reduction in the debilitating morbidities associated with the therapies. Phytochemicals have long been used in ancient systems of medicine, and non-toxic phytochemicals are being considered as new options for the effective management of cancer. Here, we discuss the growth inhibitory and anti-cell migratory actions of proanthocyanidins from grape seeds (GSPs), polyphenols in green tea and honokiol, derived from the

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Head and Neck Neoplasms; Humans; Lignans; Magnolia; Polyphenols; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Tea; Vitis

2016

Other Studies

2 other study(ies) available for lignans and Squamous-Cell-Carcinoma-of-Head-and-Neck

ArticleYear
Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:1 Pt 1

    Cancer stem cells (CSCs) have been known to be implicated in tumorigenesis, metastasis, and drug resistance in oral squamous cell carcinomas (OSCC). In this study, we aimed to investigate whether magnolol, a polyphenolic component derived from Magnolia officinalis, exhibited the anti-CSCs properties.. The cytotoxicity of magnolol was tested using normal gingival epithelioid SG cells and sphere-forming OSCC-CSCs isolated from SAS, OECM1, and GNM cells. Secondary sphere-forming ability, the proportion of ALDH1 positive cells, Transwell migration, and invasion capacities were examined as well. The chemosensitive effects of magnolol were investigated using MTT, secondary sphere-forming, and invasion assays.. Magnolol exerted a higher cytotoxicity of OSCC-CSCs and cancer stemness features, including self-renewal ability, the expression CSC marker, migration, and invasion capacities were all downregulated in magnolol-treated OSCC-CSCs. Moreover, administration of magnolol potentiated the effect of cisplatin, including a decrease in cell viability, self-renewal, and invasion activities. In addition, we observed that the secretion of IL-6 and phosphorylation of Stat3 were decreased in OSCC-CSCs treated with magnolol.. Our data suggest that magnolol is able to target CSCs and suppress the cancer stemness properties, at least in part, via IL-6/Stat3 signaling. Besides, a dietary supplement of magnolol may function as an adjunct to cisplatin treatment.

    Topics: Biphenyl Compounds; Cell Line, Tumor; Humans; Interleukin-6; Lignans; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor

2022
Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2.
    Molecules (Basel, Switzerland), 2020, May-10, Volume: 25, Issue:9

    Sesamin-treated human oral cancer cell lines FaDu, HSC-3, and Ca9-22 were subjected to a wound-healing assay. Furthermore, Western blotting was performed to assess the effect of sesamin on the expression levels of matrix metalloproteinase (MMP)-2 and proteins of the MAPK signaling pathway, including p-ERK1/2, P-p38, and p-JNK1/2. In addition, we investigated the association between MMP-2 expression and the MAPK pathway in sesamin-treated oral cancer cells. Sesamin inhibited cell migration and invasion in FaDu, Ca9-22, and HSC-3 cells and suppressed MMP-2 at noncytotoxic concentrations (0 to 40 μM). Furthermore, sesamin significantly reduced p38 MAPK and JNK phosphorylation in a dose-dependent manner in FaDu and HSC-3 cells.. These results indicate that sesamin suppresses the migration and invasion of HNSCC cells by regulating MMP-2 and is thus a potential antimetastatic agent for treating HNSCC.

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Dioxoles; Head and Neck Neoplasms; Humans; Lignans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Squamous Cell Carcinoma of Head and Neck; Zanthoxylum

2020